Chromatin/Epigenetics


Epigenetics is the heritable modifications in gene expression that is not associated with changes in DNA sequence. Epigenetic modifications occur mostly on DNA or on the histone octamer. There are several types of epigenetics modifications, DNA methylation by DNA-methyl transferase (DNMT) and covalent modification of histones (e.g. acetylation, methylation, phosphorylation and ubiquitination). Histone acetylation by histone acetyltransferases (HATs) is involved in transcriptional activation, whereas histone deacetylation by histone deacetylases (HDACs) is connected with transcriptional repression. Histone demethylation is associated with lysine-specific demethylase (LSD) and JmjC domain containing histone demethylase (JHDM).
The nucleosome is consisted of four histone proteins (H2A, H2B, H3, and H4), they are primary building block of chromatin. The addition and removal of specific chemical groups refers to as epigenetic marks, it regulates chromatin structure and affects gene expression. Moreover, RNA is intimately involved in the formation of a repressive chromatin state.
Epigenetic mechanism responds to environmental changes at the cellular level and thus influences cellular plasticity. Chromatin and epigenetic regulation play a significant role in the programming of the genome during development and stress response, defects in epigenetics can lead to cancer, inflammation and metabolic disorders etc.
-
A9994 EPZ020411 hydrochlorideSummary: A highly selective inhibitor of protein arginine methyltransferase 6 (PRMT6) -
A9997 BET-IN-19 hydrochlorideSummary: A potent BET (bromine domain and hyperterminal domain) protein inhibitor -
C8586 TFMB-(S)-2-HGSummary: An effective TET2 inhibitor -
C8689 RevumenibSummary: A potent, orally available, and highly selective inhibitor of the menin–KMT2A interaction -
B8380 KG-501Summary: A compound that inhibits CREB, with an IC50 of 6.89μM. -
B8471 Gambogenic acidSummary: Naturally derived; can covalently bind EZH2 and induce its ubiquitination and degradation. -
C3351 GSK484 (hydrochloride)Summary: A small molecule that reversibly and selectively inhibits PAD4-mediated protein citrullination. -
C3808 GSK199 (hydrochloride)Summary: A reversible, selective PAD4 inhibitor for inflammation research. -
C4419 NaphthofluoresceinSummary: Inhibitor of furin -
C4779 TetrahydrouridineSummary: A potent competitive cytidine deaminase (CDA) inhibitor.

